Posts by: Kara Elam

News

Xeomin (incobotulinumtoxinA) has been approved by the U.S. Food and Drug Administration for the treatment of chronic sialorrhea, or excessive drooling, a common condition in amyotrophic lateral sclerosis (ALS) patients. Merz Neurosciences, ... Read more

October 31, 2016

Neuroimaging Techniques Confirm Neuropathological Findings that Contribute to Degeneration in ALS

News

Advanced neuroimaging techniques and neuropsychological evaluations of patients with amyotrophic lateral sclerosis (ALS) recently confirmed the existence of a unique micro-structural brain degeneration pattern that contributes to memory loss, according ... Read more

December 22, 2015December 22, 2015

ALS Phase 3 Study of Masitinib Reaches Target Patient Enrollment

News

AB Science recently announced it has completed its targeted enrollment of 381 patients for an ongoing Phase 3 study evaluating masitinib in the treatment of amyotrophic lateral sclerosis (ALS). Masitinib is an ... Read more

November 12, 2015November 11, 2015

ALS Neuroscience Focus Turns to Promising RNA Research

News

This week the ALS Association, whose mission is to lead the fight to treat and cure ALS through global research and nationwide advocacy, has highlighted important research from the 2015 Annual ... Read more

October 12, 2015October 12, 2015

Study Findings Reveal Key Genetic Piece of ALS And Dementia Puzzle

News

University of Toronto (UT) researchers have uncovered the main genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), a discovery that will lead to the development of ... Read more

September 21, 2015September 21, 2015

Protein Misfolding and Mitochondrial Dysfunction in ALS Pathogenesis

News

Researchers from the University of Milan (UM), Italy, have recently released findings from their scientific literature review, in an effort to uncover the causes of cellular pathologies that are the hallmark of Amyotrophic ... Read more

July 27, 2015July 27, 2015

ALS Ice Bucket Challenge Returning This August to Raise Research Money

News

Last year a monumental push to increase research funding for Amyotrophic Lateral Sclerosis (ALS), known as the ALS Ice Bucket Challenge, raised over $220 million globally for ALS research ... Read more

June 8, 2015June 11, 2015

Study Findings May Lead To Future Genetic Test For ALS

News

Researchers from the University of Toronto (UT) have recently discovered a potential way to detect a genetic predisposition for Amyotrophic Lateral Sclerosis (ALS), before the debilitating symptoms of the ... Read more

April 13, 2015April 13, 2015

Exposure to Low-Frequency Magnetic Fields is not an Alzheimer’s or ALS Risk Factor

amyotrophic lateral sclerosis (ALS), News

Researchers from the Institute of Pathobiochemistry at the Medical Center of Johannes Gutenberg University Mainz, Germany, have recently released results from a study in which they used animal experiments ... Read more

April 8, 2015April 8, 2015

Kadimastem To Initiate a Human Clinical Trial for Promising ALS Therapy

amyotrophic lateral sclerosis (ALS), News

This week, Kadimastem, an innovative Israeli biotechnology company focused on the industrial development and commercialization of human pluripotent stem cell (hPSC)-based therapeutic solutions for the neurodegenerative diseases Multiple Sclerosis ... Read more

Posts by: Kara Elam

Kara Elam

FDA Approves Xeomin for Excessive Drooling, Common in ALS Patients

Neuroimaging Techniques Confirm Neuropathological Findings that Contribute to Degeneration in ALS

ALS Phase 3 Study of Masitinib Reaches Target Patient Enrollment

ALS Neuroscience Focus Turns to Promising RNA Research

Study Findings Reveal Key Genetic Piece of ALS And Dementia Puzzle

Protein Misfolding and Mitochondrial Dysfunction in ALS Pathogenesis

ALS Ice Bucket Challenge Returning This August to Raise Research Money

Study Findings May Lead To Future Genetic Test For ALS

Exposure to Low-Frequency Magnetic Fields is not an Alzheimer’s or ALS Risk Factor

Kadimastem To Initiate a Human Clinical Trial for Promising ALS Therapy

Pin It on Pinterest